Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Tagworks Pharmaceuticals BV
Tagworks Pharmaceuticals BV
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Iovance Biotherapeutics, Inc.
St. Jude Children's Research Hospital
University of Alabama at Birmingham
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Pfizer
Pfizer
Pfizer
Turning Point Therapeutics, Inc.
Taiho Oncology, Inc.
NRG Oncology
Alterome Therapeutics, Inc.
Pheon Therapeutics
Hôpital NOVO
Boston Scientific Corporation
Peking University People's Hospital
SillaJen, Inc.
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
University Hospital, Toulouse
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Roswell Park Cancer Institute
ToLymph Inc.
Emory University
Nuvectis Pharma, Inc.
George Washington University
AstraZeneca
Replimune Inc.
AstraZeneca
Avenzo Therapeutics, Inc.
Shanghai Pulmonary Hospital, Shanghai, China
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Emory University
Stanford University
Auricula Biosciences Inc.
iOMEDICO AG
DualityBio Inc.
NATCO Pharma Ltd.
Centre Francois Baclesse
Jinling Hospital, China
Tanabe Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jinling Hospital, China